EPCAM and cancer: Our study revealed that Benz reduced STAT3, NF-κB, β-catenin, and CD326/EpCAM, which are cancer cell survival factors, as well as CSC/CIC markers, concomitant with the inhibition of a number of pro-tumorigenic malignancy events.